Alnylam – Global Scientific Communications: Medical Information/Digital Engagement at Northeastern University in Boston, MA

Job description

About the Opportunity About the Opportunity Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program’s success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry. Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Scientific Communications: Medical Information/Digital Engagement fellowship, based in Cambridge, MA. About Alnylam We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another. Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Responsibilities Alnylam’s Medical Affairs organization supports marketed products, pipeline assets, and launch readiness for therapies addressing areas of unmet need. Within Global Scientific Communications, the Medical Information & Review team provides balanced, accurate, and current product information to healthcare professionals, patients, and caregivers. This work helps support the safe, effective, and appropriate use of Alnylam therapies. The Scientific Communications Strategy & Excellence team develops and executes scientific communication and engagement strategies across Global Medical Affairs. Medical Information also works cross-functionally with key internal partners to support accurate and compliant communications. Fellows will gain hands-on experience creating fair, accurate medical content while supporting scientific communications strategy. Key Responsibilities: · Global management of requests for medical information · Medical Information content development, includi